Search
Search Results
##search.searchResults.foundPlural##
-
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3277PDF: 1110HTML: 3255 -
THE TRAGEDY CAUSED BY FAKE ANTIMALARIAL DRUGS
2948PDF: 1172HTML: 2018 -
PROPHYLAXIS OF MALARIA
3179PDF: 1138HTML: 18082Figures SChwartz: 225 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2888PDF: 1133HTML: 2413 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2783PDF: 1710HTML: 749 -
Guest Editor: G. Castaman AGING WITH HEMOPHILIA: THE CHALLENGE OF APPROPRIATE DRUG PRESCRIPTION Hemophilia and aging
3119PDF: 1548HTML: 337 -
Tuberculosis after gastrectomy, plasmatic concentration of antitubercular drugs
1740PDF: 906HTML: 852tile page: 218Table 1: 226 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4522PDF: 1488HTML: 2216 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4268PDF: 1258HTML: 2140Fig.1: 252Fig. 2: 151Table 1: 262Table2: 287Table 3: 278 -
-
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277961PDF: 1924HTML: 3920 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2532PDF: 1959HTML: 1097 -
EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA
2405PDF: 1091HTML: 4998 -
ADVANCES IN THE TREATMENT OF MALARIA
3018PDF: 1401HTML: 6171 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1781PDF: 720HTML: 2459 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3758PDF: 1437HTML: 6378 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1810PDF: 1176HTML: 527 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
2013PDF: 878HTML: 3705 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4757Suppl. Files: 1293PDF: 1194Html: 345 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
3079PDF: 1074HTML: 7532 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
6027PDF: 1636HTML: 1690Untitled: 296 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1971PDF: 2179Suppl. Files: 300HTML: 126 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3591PDF: 1706HTML: 4104 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
2195PDF: 999HTML: 1118 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2778PDF: 1766HTML: 2474Table1: 310 -
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
11235PDF: 6679HTML: 21992 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2833PDF: 1284HTML: 297 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2891PDF: 1066HTML: 3771 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
5051PDF: 1929HTML: 2907Untitled: 346 -
Severe Acute Hepatitis B Treated with Entecavir
1769PDF: 950HTML: 2572Figure: 225Title page: 233disclosure: 153







